Skip to content

Study on influencing factors and intervention effect of treatment adherence in patients with chronic kidney disease

Study on influencing factors and intervention effect of treatment adherence in patients with chronic kidney disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100613
Enrollment
Unknown
Registered
2025-04-11
Start date
2025-04-30
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease

Interventions

Control group:The patient received routine clinical care and standard clinical care procedures, including admission assessment, condition monitoring, drug therapy, etc.
Test group:On the basis of routine clinical nursing, the treatment adherence intervention plan of non-dialysis CKD patients based on inhibition control was carried out, which was led by individual pat

Sponsors

Tangdu Hospital, Air Force Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meeting the diagnostic criteria for chronic kidney disease outlined in the National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines and not yet undergoing dialysis; 2. Primary diagnosis of glomerular disease with a disease duration >=3 months; 3. Aged >=18 years; 4. At least primary school education level; 5. Proficient in using smartphones; 6. Normal or corrected-to-normal vision without color blindness or color weakness; 7. Normal finger function to perform button-pressing tasks; 8. Clear consciousness with intact communication abilities; 9. Voluntary participation with written informed consent.

Exclusion criteria

Exclusion criteria: 1. Cognitive impairment (i.e., Montreal Cognitive Assessment (MoCA) score <26) or comorbid psychiatric disorders; 2. Comorbid severe cardiovascular, neurological, pulmonary, or other systemic diseases; 3. Living alone or cohabiting with non-family caregivers; 4. Current participation in other clinical trials.

Design outcomes

Primary

MeasureTime frame
treatment adherence;

Secondary

MeasureTime frame
family function;chronic disease resource utilization;inhibitory control;

Countries

China

Contacts

Public ContactLv Honghong

Department of Nephrology, Tangdu Hospital, Air Force Medical University

283360153@qq.com+86 159 9179 2275

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026